Biotie

BIOTIE SIGNS FURTHER NALMEFENE MARKETING AGREEMENTS, IS SUBMITTING MAA Printer-friendly version
27.10.2006




- Deals concluded to cover Turkey and South-Korea
- Final MAA package to be submitted to the UK MHRA imminently

Biotie Therapies Corp. has today signed marketing and distribution agreements for nalmefene with Eczacibasi Ilaç Pazarlama AS (Eczacibasi), based in Istanbul, for nalmefene in Turkey; and with Whanin Pharmaceutical Co., Ltd. (Whanin), based in Seoul, for nalmefene in South-Korea.

biotie

Mvh biohit